Answers are grounded in this paper and cite their sources.
There are a multitude of formulation factors to consider when developing a solution-based pressurized metered dose inhaler (pMDI). Evaluation of these variables and their underpinning driving force has been performed over the years. Key components, including formulation composition and device design, play significant roles in determining the aerosol performance of these solution-based formulations. This review outlines research efforts that have focused on these essential governing factors, how the aerosol performance changes when these variables are modified and fundamental mechanisms affecting the delivery efficiency of such formulations.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: